Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$22.08
-2.64 (-10.68%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $21.39 $25.74 Friday, 10th May 2024 ARWR stock ended at $22.08. This is 10.68% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 16.93% from a day low at $21.79 to a day high of $25.48.
90 days $21.39 $36.72
52 weeks $20.67 $40.89

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Dec 15, 2022 $32.34 $32.58 $31.22 $31.44 665 006
Dec 14, 2022 $32.79 $33.44 $32.35 $32.85 606 725
Dec 13, 2022 $32.88 $33.52 $31.81 $32.85 782 258
Dec 12, 2022 $30.39 $31.94 $30.12 $31.85 759 846
Dec 09, 2022 $31.34 $31.35 $30.18 $30.24 771 350
Dec 08, 2022 $33.14 $33.34 $31.38 $31.56 618 433
Dec 07, 2022 $32.15 $33.06 $31.86 $32.86 647 765
Dec 06, 2022 $31.74 $32.11 $31.32 $32.01 777 111
Dec 05, 2022 $33.71 $33.71 $31.19 $31.82 888 081
Dec 02, 2022 $31.97 $34.18 $31.37 $33.93 878 802
Dec 01, 2022 $32.31 $33.29 $31.80 $32.02 772 669
Nov 30, 2022 $30.62 $32.24 $30.03 $32.20 1 568 241
Nov 29, 2022 $28.00 $31.70 $27.75 $29.99 1 775 843
Nov 28, 2022 $29.30 $29.69 $28.00 $28.00 997 567
Nov 25, 2022 $29.29 $29.81 $29.12 $29.50 507 121
Nov 23, 2022 $29.55 $29.95 $29.07 $29.40 605 083
Nov 22, 2022 $30.10 $30.10 $28.81 $29.55 1 091 342
Nov 21, 2022 $30.55 $30.70 $29.57 $29.74 351 887
Nov 18, 2022 $31.26 $31.26 $30.54 $30.68 345 637
Nov 17, 2022 $31.05 $31.34 $30.14 $30.26 426 785
Nov 16, 2022 $33.60 $33.76 $31.36 $31.73 533 436
Nov 15, 2022 $34.37 $34.77 $32.95 $33.89 599 938
Nov 14, 2022 $34.30 $34.62 $33.50 $33.63 426 103
Nov 11, 2022 $34.75 $35.50 $33.64 $34.67 667 306
Nov 10, 2022 $32.30 $35.11 $32.00 $34.76 1 074 615
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT